TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05912556

Intervention type: DEVICE
Group type: OTHER
Intervention: Digital Program 1
Description: 2/3 of randomized subjects use digital program 1 for 12 weeks to provide mental stimulation

Intervention type: DEVICE
Group type: OTHER
Intervention: Digital Program 1
Description: 2/3 of randomized subjects use digital program 1 for 12 weeks to provide mental stimulation

Intervention type: DEVICE
Group type: OTHER
Intervention: Digital Program 2
Description: 1/3 of randomized subjects use digital program 2 for 12 weeks to provide mental stimulation

Intervention type: DEVICE
Group type: OTHER
Intervention: Digital Program 2
Description: 1/3 of randomized subjects use digital program 2 for 12 weeks to provide mental stimulation
Study: NCT05989828

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy of breast tumor

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo breast MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mammogram
Description: Undergo mammogram

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA scan

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound Imaging
Description: Undergo ultrasound of breast
Study: NCT06141811

Intervention type: BIOLOGICAL
Intervention: ALLO-ASC-DFU
Description: Application of ALLO-ASC-DFU sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.

Intervention type: PROCEDURE
Intervention: Vehicle sheet
Description: Application of Vehicle sheet to Diabetic Foot Ulcer. This study is a follow-up study without intervention.
Study: NCT05081492

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Oncolytic Virus CF33-expressing hNIS/Anti-PD-L1 Antibody
Description: Given IT
Study: NCT06385834

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Morning aerobic exercise
Description: Patients were randomly assigned to morning aerobic exercise training for a 12-week outpatient training program that included a combination of warm-up, aerobic, and relaxation exercises three times a week. Each class consists of 10 minutes of warm-up training, 40 minutes of aerobic training and 10 minutes of relaxation training. The intensity of aerobic exercise training will be personalized. According to the guidance of relevant guidelines, the exercise intensity of patients will be determined according to the results of their first cardiopulmonary exercise experiment, and the exercise load will be gradually increased according to the exercise program until the predetermined goal is reached. Patient fatigue levels will be monitored throughout the exercise using the borg scale.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Evening aerobic exercise
Description: Patients were randomly assigned to evening aerobic exercise training for a 12-week outpatient training program that included a combination of warm-up, aerobic, and relaxation exercises three times a week. Each class consists of 10 minutes of warm-up training, 40 minutes of aerobic training and 10 minutes of relaxation training. The intensity of aerobic exercise training will be personalized. According to the guidance of relevant guidelines, the exercise intensity of patients will be determined according to the results of their first cardiopulmonary exercise experiment, and the exercise load will be gradually increased according to the exercise program until the predetermined goal is reached. Patient fatigue levels will be monitored throughout the exercise using the borg scale.
Study: NCT05722353

Intervention type: OTHER
Group type: OTHER
Intervention: Biocollection
Description: Collection of blood samples and feces specimen at inclusion visit; clinical and biological assessment at each visit.
Study: NCT05789940

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hysteroscopy
Description: The procedure is performed by a gynecologic surgeon under general or spinal anesthesia, depending on the standard practice of the center involved, with the patient in the gynecologic position. Antibiotic prophylaxis may be administered according to the standard practice of the center. The equipment available at each center will be used for operative hysteroscopy. The use of energy is usually unnecessary and saline will be preferred. Before the operation, the appearance of the uterine cavity will be described. The selected design product will be resected from top to bottom using the surgical resector, without electrical energy, as this method is known to be the most protective of the endometrium in previous studies. Electric current should be used only as a last resort, in cases where the selected design cannot be removed without it. If there is active bleeding after the procedure, elective coagulation via the hysteroscope may be performed to stop intrauterine bleeding.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Aspiration
Description: The aspiration will be performed by a gynecological surgeon, according to the center's standard protocol. A flexible or rigid cannula can be used. Antibiotic prophylaxis, the diameter of the cannula used, the cervical preparation required, and the use of intraoperative ultrasound guidance will be left to the discretion of the operator and the standard practice of the center. In most centers, the cervix is dilated with a Hegar dilator of up to 9 mm in size.
Study: NCT06079879

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bomedemstat
Description: Oral Capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anagrelide
Description: Oral Capsule

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan
Description: Oral Tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Interferon alfa/pegylated interferon alfa
Description: Subcutaneous Solution

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ruxolitinib
Description: Oral Tablet
Study: NCT05571631

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Arm ergometer will aplied as an aerobic exercise. Combination of balance training and arm ergometer exerise program will applied.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: Arm ergometer will aplied as an aerobic exercise. Combination of balance training and arm ergometer exerise program will applied.
Study: NCT04908774

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fasting Mimicking Diet
Description: The mobile application Salufast provides standardised fasting packages for 5 days of approx. 500 kcal and accompanies the participants during all fasting days.
Study: NCT05445505

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: intermittent theta burst stimulation
Description: iTBS is a new form of excitatory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: intermittent theta burst stimulation
Description: iTBS is a new form of excitatory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intermittent theta burst stimulation
Description: iTBS is a new form of excitatory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intermittent theta burst stimulation
Description: iTBS is a new form of excitatory rTMS treatment that is less time-consuming and more effective than traditional rTMS in a single treatment session.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham iTBS
Description: The pseudo-stimulation device looks and sounds the same as the iTBS device

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham iTBS
Description: The pseudo-stimulation device looks and sounds the same as the iTBS device
Study: NCT05300711

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral salpingectomy
Description: Removal of both fallopian tubes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Colorectal surgery
Description: Colorectal surgery as indicated by attending surgeon.
Study: NCT05717868

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiology taping
Description: 5 cm wide and 0.5 mm thick waterproof, porous and adhesive tape will be applied to the posterior neck of the participants while sitting comfortably in a neutral position. The first tape (Y-strip) is placed over the posterior cervical extensor muscles with approximately 25% tension. The top strip will be placed perpendicular to the Y strip on the mid-cervical region. The participant's cervical spine is flexed to obtain tension in the posterior structures.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-mobilization
Description: The towel will be placed on the posterior arch of the fifth cervical vertebra and pulled horizontally across the face. The participant will be instructed to apply pressure to the towel and turn their head to the restricted side, then maintain the finishing interval for three seconds. The participant will be asked to apply extreme pressure in the bending position with towel support. The procedure should be painless and repeated 10 times.
Study: NCT05873855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Para ti, para mi, para nosotros (P3)
Description: From day 1 to day 180 (i.e., entire 6-month duration, post baseline) of the pilot trial, participants randomized to the intervention arm will have access to use the five modules as directed. The P3 intervention includes modules focused on topics of: HIV/STI prevention, sexual agreements, communication/decision-making skills, strengthening relationships and creating goals, and physical activity.
Study: NCT04716114

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SKLB1028
Description: SKLB1028 will be administered by oral capsules, 150 mg twice daily (BID).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Salvage Chemotherapy
Description: Low-dose cytarabine (LoDAC); azacytidine; homoharringtonine (HHT), cytarabine and aclarubicin (HAA) or fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG) will be administered by subcutaneous (SC) and/or intravenous (IV) injections.
Study: NCT04942041

Intervention type: OTHER
Intervention: Simulation based quality program
Description: Stroke team simulation. Virtual reality task training simulation.
Study: NCT05873855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Waitlist Control Para ti, para mi, para nosotros (P3)
Description: From day 91 to day 180 (i.e., starting after 3-month assessment) of the pilot trial, participants randomized to the waitlist control condition will have access to use the five modules as directed. The P3 intervention includes modules focused on topics of: HIV/STI prevention, sexual agreements, communication/decision-making skills, strengthening relationships and creating goals, and physical activity.
Study: NCT05367245

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cal-Mag Butyrate
Description: Supplements

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Only Cal-Mag but no Butyric acid
Study: NCT05164744

Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac MRI
Description: Patients participate in an NIH funded cardiac MRI to assess their symptoms.

Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiogram
Description: Patients participate in an NIH funded cardiac echocardiogram to assess their symptoms.

Intervention type: DIAGNOSTIC_TEST
Intervention: 6-minute walk test
Description: Patients participate in a 6-minute walk test to assess their symptoms.

Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaire
Description: Patients answer a survey-based questionnaire to assess their symptoms.
Study: NCT04729257

Intervention type: DEVICE
Group type: OTHER
Intervention: Philips IntelliSpace Cognition (ISC).
Description: Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

Intervention type: DEVICE
Group type: OTHER
Intervention: Philips IntelliSpace Cognition (ISC).
Description: Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

Intervention type: DEVICE
Group type: OTHER
Intervention: Philips IntelliSpace Cognition (ISC).
Description: Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

Intervention type: DEVICE
Group type: OTHER
Intervention: Philips IntelliSpace Cognition (ISC).
Description: Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

Intervention type: DEVICE
Group type: OTHER
Intervention: Philips IntelliSpace Cognition (ISC).
Description: Philips ISC is a Class-II Medical Device in the US that aids in assessing cognition and helps inform the HealthCare Professional (HCP) to make a diagnosis and treatment plan. ISC can be used in a variety of healthcare environments such as neurology and neuropsychology practices.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Paper-Pencil Tests.
Description: The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Paper-Pencil Tests.
Description: The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice.

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Paper-Pencil Tests.
Description: The same cognitive tests that are on the ISC platform are performed using paper and pencil (rather than digitally) as is the case in standard clinical practice.
Study: NCT06426537

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine 0.5 MG Oral Tablet
Description: Oral administration of Colchicine in STEMI patients

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colchicine 0.5 MG Oral Tablet
Description: Oral administration of Colchicine in STEMI patients

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Colchicine 0.5 MG Oral Tablet
Description: Oral administration of Colchicine in STEMI patients

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Colchicine 0.5 MG Oral Tablet
Description: Oral administration of Colchicine in STEMI patients
Study: NCT06579573

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cenobamate
Description: Cenobamate will be orally administered once daily.
Study: NCT05403008

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Zirconomer improved
Description: Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.

Intervention type: OTHER
Group type: OTHER
Intervention: Zirconomer improved
Description: Zirconomer improved, is a nano zirconia reinforced glass ionomer, which has improved the mechanical, esthetic and handling properties than its previous successor.
Study: NCT06136624

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opevesostat
Description: Administered orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abiraterone acetate
Description: Administered orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enzalutamide
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Description: Administered orally or IM as a rescue medication

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludrocortisone acetate
Description: Administered orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: Administered orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Administered orally as rescue medication
Study: NCT06111690

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction Training (BFRT)
Description: Participants will be performing low-resistance exercise with (BFRT). Intervention will start at least seven days after initial evaluation, so it does not influence measures of real-time physical activity. We will use a log to register exercise completion and to record bilateral knee pain before, during and after each intervention session
Study: NCT06637319

Intervention type: DEVICE
Intervention: Ultrasound
Description: Ultrasound scan of blood vessels where front of neck access vertical incision would take place in a cant intubate cant oxygenate scenario
Study: NCT06240442

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fasted exercise
Description: Bodyweight interval exercise performed 5 minutes before the start of a mixed-macronutrient breakfast meal

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fed exercise
Description: Bodyweight interval exercise performed 10 minutes after the start of consuming a mixed-macronutrient breakfast meal
Study: NCT05909332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antivascular therapy
Description: BP102 (anti VEGFR)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: ddEC-P

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: ddEC-P
Study: NCT04997369

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rezum
Description: The Rezum system is an ablative procedure for patients with benign prostatic hyperplasia (BPH).
Study: NCT05521516

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Percutaneous Auricular Neuromodulation with NSS-2 Bridge
Description: Application of 5 days of percutaneous auricular neuromodulation with NSS-2 Bridge device

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Treatment
Description: Application of 5 days of a nonfunctional sham device
Study: NCT06502990

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metreleptin
Description: Metreleptin is a recombinant human leptin analog that is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency
Study: NCT04783155

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: POWERBreathe Plus®
Description: Commercially available pressure-threshold device

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: POWERBreathe Plus®
Description: Commercially available pressure-threshold device

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cardiopulmonary rehabilitation post lung transplant
Description: Pulmonary function, lung diffusing capacity for carbon monoxide, inspiratory muscle strength, and diaphragm dimensions will be assessed in each patient. Each patient will also undergo a cardiopulmonary exercise test (CPET), 6 minute walk test, and an inspiratory muscle endurance test

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cardiopulmonary rehabilitation post lung transplant
Description: Pulmonary function, lung diffusing capacity for carbon monoxide, inspiratory muscle strength, and diaphragm dimensions will be assessed in each patient. Each patient will also undergo a cardiopulmonary exercise test (CPET), 6 minute walk test, and an inspiratory muscle endurance test
Study: NCT05326776

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pitocin
Description: At each session, 4mcg/2ml oxytocin or 2ml isotonic saline (0.9% sodium chloride; placebo control) will be injected into the middle of the dorsal forearm. Sessions will be separated by at least 48 hours to ensure drug clearance.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pitocin
Description: At each session, 4mcg/2ml oxytocin or 2ml isotonic saline (0.9% sodium chloride; placebo control) will be injected into the middle of the dorsal forearm. Sessions will be separated by at least 48 hours to ensure drug clearance.
Study: NCT05642715

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: EX+
Description: All participants, regardless of study arm, will be offered: BecomeAnEX, an online tobacco treatment with support community PLUS Positively Smoke Free on the Web (an intervention targeting people with HIV who smoke) integrated into the BecomeAnEX site.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: EX+
Description: All participants, regardless of study arm, will be offered: BecomeAnEX, an online tobacco treatment with support community PLUS Positively Smoke Free on the Web (an intervention targeting people with HIV who smoke) integrated into the BecomeAnEX site.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Varenicline
Description: All participants, regardless of study arm, will be offered: A 12-week course of varenicline dosed according to product label.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varenicline
Description: All participants, regardless of study arm, will be offered: A 12-week course of varenicline dosed according to product label.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HR
Description: Participants allocated to the EX+/HR arm will be offered: 30-minute video urging smokers who cannot or will not quit to cut down on cigarettes, and also to control their risk for lung cancer and cardio or cerebrovascular disease by undergoing low-dose CT screening for lung cancer (for those meeting prespecified criteria), and referral to Cardiometabolic Clinic (for those meeting prespecified criteria).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TAU
Description: Participants allocated to the EX+/TAU arm will be offered: Medical treatment as usual from their regular providers after completing Stage 1 of the study